Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11

1.

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer.

Wong HY, Wang GM, Croessmann S, Zabransky DJ, Chu D, Garay JP, Cidado J, Cochran RL, Beaver JA, Aggarwal A, Liu ML, Argani P, Meeker A, Hurley PJ, Lauring J, Park BH.

Oncotarget. 2015 Dec 29;6(42):44927-40. doi: 10.18632/oncotarget.6743.

2.

A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).

Yu XF, Yang HJ, Yu Y, Zou DH, Miao LL.

PLoS One. 2015 Aug 27;10(8):e0136670. doi: 10.1371/journal.pone.0136670. eCollection 2015.

3.

The prognostic value of clinical and pathologic features in nonmetastatic operable male breast cancer.

Sun B, Zhang LN, Zhang J, Zhang N, Gu L.

Asian J Androl. 2016 Jan-Feb;18(1):90-5. doi: 10.4103/1008-682X.154992.

4.

Male breast carcinoma: a clinicopathological and immunohistochemical characterization study.

Zhou R, Yu L, Zhou S, Bi R, Shui R, Yu B, Lu H, Cai X, Yang W.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6852-61. eCollection 2014.

5.

Challenges in the development of future treatments for breast cancer stem cells.

Patel SA, Ndabahaliye A, Lim PK, Milton R, Rameshwar P.

Breast Cancer (Dove Med Press). 2010 Mar 10;2:1-11. eCollection 2010. Review.

6.

HER2-positive male breast cancer: an update.

Ottini L, Capalbo C, Rizzolo P, Silvestri V, Bronte G, Rizzo S, Russo A.

Breast Cancer (Dove Med Press). 2010 Oct 4;2:45-58. doi: 10.2147/BCTT.S6519. Review.

7.

Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer.

Vermeulen JF, Kornegoor R, van der Wall E, van der Groep P, van Diest PJ.

PLoS One. 2013;8(1):e53353. doi: 10.1371/journal.pone.0053353. Epub 2013 Jan 4.

8.

Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.

Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, Marchionni L, van Diest PJ.

Breast Cancer Res Treat. 2012 Aug;135(1):49-58. doi: 10.1007/s10549-012-2051-3. Epub 2012 Apr 13.

9.

The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow.

Reddy BY, Lim PK, Silverio K, Patel SA, Won BW, Rameshwar P.

Int J Breast Cancer. 2012;2012:721659. doi: 10.1155/2012/721659. Epub 2012 Feb 6.

10.

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.

Johansson I, Nilsson C, Berglund P, Lauss M, Ringnér M, Olsson H, Luts L, Sim E, Thorstensson S, Fjällskog ML, Hedenfalk I.

Breast Cancer Res. 2012 Feb 14;14(1):R31.

11.

Matched-pair analysis of patients with female and male breast cancer: a comparative analysis.

Foerster R, Foerster FG, Wulff V, Schubotz B, Baaske D, Wolfgarten M, Kuhn WC, Rudlowski C.

BMC Cancer. 2011 Aug 4;11:335. doi: 10.1186/1471-2407-11-335.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk